These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17695727)

  • 21. DNA damage response: the emerging role of c-Abl as a regulatory switch?
    Maiani E; Diederich M; Gonfloni S
    Biochem Pharmacol; 2011 Nov; 82(10):1269-76. PubMed ID: 21763684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.
    Yoshida K; Komatsu K; Wang HG; Kufe D
    Mol Cell Biol; 2002 May; 22(10):3292-300. PubMed ID: 11971963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells.
    Sirvent A; Benistant C; Roche S
    Biol Cell; 2008 Nov; 100(11):617-31. PubMed ID: 18851712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Abl: activation and nuclear targets.
    Shaul Y
    Cell Death Differ; 2000 Jan; 7(1):10-6. PubMed ID: 10713716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage stress response in germ cells: role of c-Abl and clinical implications.
    Gonfloni S
    Oncogene; 2010 Nov; 29(47):6193-202. PubMed ID: 20818431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of long and winding nuclear F-actin bundles by nuclear c-Abl tyrosine kinase.
    Aoyama K; Yuki R; Horiike Y; Kubota S; Yamaguchi N; Morii M; Ishibashi K; Nakayama Y; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    Exp Cell Res; 2013 Dec; 319(20):3251-68. PubMed ID: 24041959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.
    Mao X; Yu CR; Li WH; Li WX
    Cell Res; 2008 Aug; 18(8):879-88. PubMed ID: 18663379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferating cell nuclear antigen destabilizes c-Abl tyrosine kinase and regulates cell apoptosis in response to DNA damage.
    He X; Wei C; Song T; Yuan J; Zhang Y; Ma Q; Shi W; Zhong H
    Apoptosis; 2009 Mar; 14(3):268-75. PubMed ID: 19156526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear c-Abl-mediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation.
    Aoyama K; Fukumoto Y; Ishibashi K; Kubota S; Morinaga T; Horiike Y; Yuki R; Takahashi A; Nakayama Y; Yamaguchi N
    Exp Cell Res; 2011 Dec; 317(20):2874-903. PubMed ID: 22001646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Abl tyrosine kinase regulates serum-induced nuclear export of diacylglycerol kinase α by phosphorylation at Tyr-218.
    Matsubara T; Ikeda M; Kiso Y; Sakuma M; Yoshino K; Sakane F; Merida I; Saito N; Shirai Y
    J Biol Chem; 2012 Feb; 287(8):5507-17. PubMed ID: 22199356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of hematopoietic progenitor kinase 1 and c-Abl tyrosine kinase in response to genotoxic stress.
    Ito Y; Pandey P; Sathyanarayana P; Ling P; Rana A; Weichselbaum R; Tan TH; Kufe D; Kharbanda S
    J Biol Chem; 2001 May; 276(21):18130-8. PubMed ID: 11278340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.
    Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Santucci MA
    Traffic; 2009 Jun; 10(6):637-47. PubMed ID: 19220809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA damage-activated ABL-MyoD signaling contributes to DNA repair in skeletal myoblasts.
    Simonatto M; Marullo F; Chiacchiera F; Musaró A; Wang JY; Latella L; Puri PL
    Cell Death Differ; 2013 Dec; 20(12):1664-74. PubMed ID: 24056763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal c-abl gene protein--a nuclear component.
    Dhut S; Chaplin T; Young BD
    Oncogene; 1991 Aug; 6(8):1459-64. PubMed ID: 1886716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway.
    Yogev O; Saadon K; Anzi S; Inoue K; Shaulian E
    Cancer Res; 2008 Mar; 68(5):1398-406. PubMed ID: 18316603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways.
    Gomel R; Xiang C; Finniss S; Lee HK; Lu W; Okhrimenko H; Brodie C
    Mol Cancer Res; 2007 Jun; 5(6):627-39. PubMed ID: 17579121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Abl-mediated tyrosine phosphorylation of JunB is required for Adriamycin-induced expression of p21.
    Yamaguchi N; Yuki R; Kubota S; Aoyama K; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    Biochem J; 2015 Oct; 471(1):67-77. PubMed ID: 26217035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species.
    Sun X; Majumder P; Shioya H; Wu F; Kumar S; Weichselbaum R; Kharbanda S; Kufe D
    J Biol Chem; 2000 Jun; 275(23):17237-40. PubMed ID: 10770918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.